{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T23:27:48Z","timestamp":1792106868706,"version":"4.4.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001691","name":"KAKENHI","doi-asserted-by":"crossref","award":["17H05081"],"award-info":[{"award-number":["17H05081"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1007\/s10620-022-07431-w","type":"journal-article","created":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T13:02:38Z","timestamp":1646139758000},"page":"5227-5238","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Chemoprevention for Colorectal Cancers: Are Chemopreventive Effects Different Between Left and Right Sided Colorectal Cancers?"],"prefix":"10.1007","volume":"67","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4905-7046","authenticated-orcid":false,"given":"Junya","family":"Arai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobumi","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryota","family":"Niikura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Ooki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuya","family":"Kawahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuro","family":"Honda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenkei","family":"Hasatani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naohiro","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsutomu","family":"Nishida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Sumiyoshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu","family":"Kiyotoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Ikeya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Arai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rei","family":"Ishibashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomonori","family":"Aoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosuke","family":"Tsuji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobutake","family":"Yamamichi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3988-2499","authenticated-orcid":false,"given":"Yoku","family":"Hayakawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuhiro","family":"Fujishiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,1]]},"reference":[{"key":"7431_CR1","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1053\/j.gastro.2019.06.047","volume":"158","author":"BW Katona","year":"2020","unstructured":"Katona BW, Weiss JM. Chemoprevention of Colorectal Cancer. Gastroenterology 2020;158:368\u2013388.","journal-title":"Gastroenterology"},{"key":"7431_CR2","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1016\/S0140-6736(07)60747-8","volume":"369","author":"E Flossmann","year":"2007","unstructured":"Flossmann E, Rothwell PM, British Doctors Aspirin T. British doctors aspirin trial and the UK-TIA aspirin trial. Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies. Lancet 2007;369:1603\u20131613.","journal-title":"Lancet"},{"key":"7431_CR3","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1053\/j.gastro.2006.08.079","volume":"131","author":"JA Baron","year":"2006","unstructured":"Baron JA, Sandler RS, Bresalier RS et al. A randomized trial of rofecoxib for the chemoprevention of colorectal adenomas. Gastroenterology 2006;131:1674\u20131682.","journal-title":"Gastroenterology"},{"key":"7431_CR4","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1158\/1055-9965.EPI-17-0424","volume":"27","author":"MC Bradley","year":"2018","unstructured":"Bradley MC, Ferrara A, Achacoso N et al. A cohort study of metformin and colorectal cancer risk among patients with diabetes mellitus. Cancer Epidemiol Biomarkers Prev 2018;27:525\u2013530.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"7431_CR5","doi-asserted-by":"publisher","first-page":"2184","DOI":"10.1056\/NEJMoa043792","volume":"352","author":"JN Poynter","year":"2005","unstructured":"Poynter JN, Gruber SB, Higgins PD et al. Statins and the risk of colorectal cancer. N Engl J Med 2005;352:2184\u20132192.","journal-title":"N Engl J Med"},{"key":"7431_CR6","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1080\/01635581.2013.804101","volume":"66","author":"ED Kantor","year":"2014","unstructured":"Kantor ED, Lampe JW, Peters U et al. Long-chain omega-3 polyunsaturated fatty acid intake and risk of colorectal cancer. Nutr Cancer 2014;66:716\u2013727.","journal-title":"Nutr Cancer"},{"key":"7431_CR7","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1002\/ijc.23718","volume":"123","author":"H Xiao","year":"2008","unstructured":"Xiao H, Yang CS. Combination regimen with statins and NSAIDs: a promising strategy for cancer chemoprevention. Int J Cancer 2008;123:983\u2013990.","journal-title":"Int J Cancer"},{"key":"7431_CR8","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1002\/ijc.22796","volume":"121","author":"M Hoffmeister","year":"2007","unstructured":"Hoffmeister M, Chang-Claude J, Brenner H. Individual and joint use of statins and low-dose aspirin and risk of colorectal cancer: a population-based case-control study. Int J Cancer. 2007;121:1325\u20131330.","journal-title":"Int J Cancer."},{"key":"7431_CR9","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1002\/ijc.28387","volume":"134","author":"P Roepman","year":"2014","unstructured":"Roepman P, Schlicker A, Tabernero J et al. Colorectal cancer intrinsic subtypes predict chemotherapy benefit, deficient mismatch repair and epithelial-to-mesenchymal transition. Int J Cancer 2014;134:552\u2013562.","journal-title":"Int J Cancer"},{"key":"7431_CR10","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1002\/path.4212","volume":"231","author":"E Budinska","year":"2013","unstructured":"Budinska E, Popovici V, Tejpar S et al. Gene expression patterns unveil a new level of molecular heterogeneity in colorectal cancer. J Pathol 2013;231:63\u201376.","journal-title":"J Pathol"},{"key":"7431_CR11","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/1755-8794-5-66","volume":"5","author":"A Schlicker","year":"2012","unstructured":"Schlicker A, Beran G, Chresta CM et al. Subtypes of primary colorectal tumors correlate with response to targeted treatment in colorectal cell lines. BMC Med Genomics 2012;5:66.","journal-title":"BMC Med Genomics"},{"key":"7431_CR12","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1038\/nm.3174","volume":"19","author":"E De Sousa","year":"2013","unstructured":"De Sousa E, Melo F, Wang X, Jansen M et al. Poor-prognosis colon cancer is defined by a molecularly distinct subtype and develops from serrated precursor lesions. Nat Med 2013;19:614\u2013618.","journal-title":"Nat Med"},{"key":"7431_CR13","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1038\/nm.3175","volume":"19","author":"A Sadanandam","year":"2013","unstructured":"Sadanandam A, Lyssiotis CA, Homicsko K et al. A colorectal cancer classification system that associates cellular phenotype and responses to therapy. Nat Med 2013;19:619\u2013625.","journal-title":"Nat Med"},{"key":"7431_CR14","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1038\/nm.3967","volume":"21","author":"J Guinney","year":"2015","unstructured":"Guinney J, Dienstmann R, Wang X et al. The consensus molecular subtypes of colorectal cancer. Nat Med 2015;21:1350\u20131356.","journal-title":"Nat Med"},{"key":"7431_CR15","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1080\/14737140.2018.1442217","volume":"18","author":"SY Yang","year":"2018","unstructured":"Yang SY, Cho MS, Kim NK. Difference between right-sided and left-sided colorectal cancers: from embryology to molecular subtype. Expert Rev Anticancer Ther 2018;18:351\u2013358.","journal-title":"Expert Rev Anticancer Ther"},{"key":"7431_CR16","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1038\/ajg.2012.161","volume":"107","author":"DK Rex","year":"2012","unstructured":"Rex DK, Ahnen DJ, Baron JA et al. Serrated lesions of the colorectum: review and recommendations from an expert panel. Am J Gastroenterol 2012;107:1315\u20131329.","journal-title":"Am J Gastroenterol"},{"key":"7431_CR17","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373\u2013383.","journal-title":"J Chronic Dis"},{"key":"7431_CR18","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1186\/s12885-020-06784-7","volume":"20","author":"K Mukund","year":"2020","unstructured":"Mukund K, Syulyukina N, Ramamoorthy S et al. Right and left-sided colon cancers - specificity of molecular mechanisms in tumorigenesis and progression. BMC Cancer 2020;20:317.","journal-title":"BMC Cancer"},{"key":"7431_CR19","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1158\/1940-6207.CAPR-15-0363","volume":"9","author":"P Kanth","year":"2016","unstructured":"Kanth P, Bronner MP, Boucher KM et al. Gene Signature in Sessile Serrated Polyps Identifies Colon Cancer Subtype. Cancer Prev Res (Phila) 2016;9:456\u2013465.","journal-title":"Cancer Prev Res (Phila)"},{"key":"7431_CR20","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1111\/apt.12115","volume":"37","author":"EB Ostenfeld","year":"2012","unstructured":"Ostenfeld EB, Erichsen R, Thorlacius-Ussing O, Riis AH, S\u00f8rensen HT. Use of systemic glucocorticoids and the risk of colorectal cancer. Aliment Pharmacol Ther 2012;37:146\u2013152.","journal-title":"Aliment Pharmacol Ther"},{"key":"7431_CR21","doi-asserted-by":"publisher","first-page":"29","DOI":"10.2174\/1568009043481632","volume":"4","author":"CV Rao","year":"2004","unstructured":"Rao CV, Reddy BS. NSAIDs and chemoprevention. Curr Cancer Drug Targets 2004;4:29\u201342.","journal-title":"Curr Cancer Drug Targets"},{"key":"7431_CR22","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.3748\/wjg.v12.i8.1261","volume":"12","author":"M Tabuchi","year":"2006","unstructured":"Tabuchi M, Kitayama J, Nagawa H. Hypertriglyceridemia is positively correlated with the development of colorectal tubular adenoma in Japanese men. World J Gastroenterolc 2006;12:1261\u20131264.","journal-title":"World J Gastroenterolc"},{"key":"7431_CR23","first-page":"02979","volume":"S0016\u20135085","author":"J Ecker","year":"2021","unstructured":"Ecker J, Benedetti E, Kindt ASD et al. The colorectal cancer lipidome \u2013 identification of a robust tumor-specific lipid species signature. Gastroenterology 2021;S0016\u20135085:02979\u201302986.","journal-title":"Gastroenterology"},{"key":"7431_CR24","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.jcmgh.2019.04.002","volume":"8","author":"L Fennell","year":"2019","unstructured":"Fennell L, Dumenil T, Wockner L et al. Integrative Genome-Scale DNA Methylation Analysis of a Large and Unselected Cohort Reveals 5 Distinct Subtypes of Colorectal Adenocarcinomas. Cell Mol Gastroenterol Hepatol. 2019;8:269\u2013290.","journal-title":"Cell Mol Gastroenterol Hepatol."},{"key":"7431_CR25","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1001\/jamaoncol.2016.4227","volume":"3","author":"F Petrelli","year":"2017","unstructured":"Petrelli F, Tomasello G, Borgonovo K et al. Prognostic Survival Associated With Left-Sided vs Right-Sided Colon Cancer: A Systematic Review and Meta-Analysis. JAMA Oncol. 2017;3:211\u2013219.","journal-title":"JAMA Oncol."},{"key":"7431_CR26","doi-asserted-by":"crossref","unstructured":"Pan M, Jiang C, Tse P, et al. TP53 Gain-of-Function and Non-Gain-of-Function Mutations Are Differentially Associated With Sidedness-Dependent Prognosis in Metastatic Colorectal Cancer. J Clin Oncol. 2021: JCO2102014.","DOI":"10.1200\/JCO.21.02014"},{"key":"7431_CR27","doi-asserted-by":"crossref","unstructured":"H Elsaleh FRANZCR, F Grieu BSc, N Zeps PhD, N Spry FRANZCR, D Joseph FRANZCR. Association of tumour site and sex with survival benefit from adjuvant chemotherapy in colorectal cancer. Lancet 2000; 355: 1745\u201350.","DOI":"10.1016\/S0140-6736(00)02261-3"},{"key":"7431_CR28","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1136\/gutjnl-2016-312712","volume":"67","author":"CA Doubeni","year":"2018","unstructured":"Doubeni CA, Corley DA, Quinn VP et al. Effectiveness of screening colonoscopy in reducing the risk of death from right and left colon cancer: a large community-based study. Gut 2018;67:291\u2013298.","journal-title":"Gut"},{"issue":"3","key":"7431_CR29","doi-asserted-by":"publisher","first-page":"dju427","DOI":"10.1093\/jnci\/dju427","volume":"107","author":"F Loupakis","year":"2015","unstructured":"Loupakis F, Yang D, Yau L et al. Primary tumor location as a prognostic factor in metastatic colorectal cancer. J Natl Cancer Inst 2015;107:dju427.","journal-title":"J Natl Cancer Inst"},{"key":"7431_CR30","doi-asserted-by":"crossref","unstructured":"Modest DP, Schulz C, von Weikersthal LF, et al. Outcome of patients with metastatic colorectal cancer depends on the primary tumor site (midgut vs. hindgut): analysis of the FIRE1-trial (FuFIRI or mIROX as first-line treatment). Anticancer Drugs. 2014 Feb; 25(2):212\u20138.","DOI":"10.1097\/CAD.0000000000000041"},{"key":"7431_CR31","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1093\/annonc\/mdy337","volume":"29","author":"K Chang","year":"2018","unstructured":"Chang K, Willis JA, Reumers J et al. Colorectal premalignancy is associated with consensus molecular subtypes 1 and 2. Annals of Oncol. 2018;29:2061\u20132067.","journal-title":"Annals of Oncol."},{"key":"7431_CR32","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1053\/j.gastro.2006.08.039","volume":"132","author":"LG Van der Flier","year":"2007","unstructured":"Van der Flier LG, Sabates-Bellver J, Oving I et al. The Intestinal Wnt\/TCF Signature. Gastroenterology. 2007;132:628\u2013632.","journal-title":"Gastroenterology."},{"key":"7431_CR33","doi-asserted-by":"crossref","unstructured":"De Sousa E Melo F, Wang X, J et al. Poor-prognosis colon cancer is defined by a molecularly distinct subtype and develops from serrated precursor lesions. Nat Med. 2013;19(5):614\u20138.","DOI":"10.1038\/nm.3174"},{"key":"7431_CR34","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1053\/j.gastro.2020.01.004","volume":"159","author":"EE Low","year":"2020","unstructured":"Low EE, Demb J, Liu L, Earles A et al. Risk Factors for Early-Onset Colorectal Cancer. Gastroenterology. 2020;159:492\u2013501.","journal-title":"Gastroenterology."},{"key":"7431_CR35","doi-asserted-by":"publisher","first-page":"2752","DOI":"10.1016\/j.cgh.2019.10.009","volume":"18","author":"V Gausman","year":"2020","unstructured":"Gausman V, Dornblaser D, Anand S, Hayes RB, O\u2019Connell K, Du M, Liang PS. Risk Factors Associated With Early-Onset Colorectal Cancer. Clin Gastroenterol Hepatol. 2020;18:2752\u20132759.","journal-title":"Clin Gastroenterol Hepatol."}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-022-07431-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-022-07431-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-022-07431-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,22]],"date-time":"2022-10-22T05:23:48Z","timestamp":1666416228000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-022-07431-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,1]]},"references-count":35,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["7431"],"URL":"https:\/\/doi.org\/10.1007\/s10620-022-07431-w","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,1]]},"assertion":[{"value":"16 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no conflict of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study included DPC database analysis (ID: 10329) and tissue sample analysis (ID: 11537), which was approved by the institutional review boards of the University of Tokyo.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Patient consent was waived because DPC data are anonymous. For tissue sample analysis, a written informed consent was obtained individually.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}